Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adderall XR for Processing Speed in MS
NCT01667484Phase 3Completed
- Sponsor
- London Health Sciences Centre
- Start
- Sep 2012
- Primary completion
- Feb 2013
- Modality
- Small Molecules, Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 3 trial of adderall xr in multiple sclerosis (MS), sponsored by London Health Sciences Centre. Started Sep 2012; status: completed.
02
Drugs
adderall xr
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT01667484.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01667484.